Economic Analysis of Gene Expression Profile Data to Guide Adjuvant Treatment in Women with Early-Stage Breast Cancer

被引:17
作者
Cosler, Leon E. [1 ]
Lyman, Gary H. [2 ,3 ]
机构
[1] Albany Coll Pharm & Hlth Sci, Dept Pharm Practice, Albany, NY 12208 USA
[2] Duke Univ, Dept Med, Durham, NC USA
[3] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
关键词
QUALITY-OF-LIFE; ADJUSTED SURVIVAL; CHEMOTHERAPY; TAMOXIFEN; COST; PREDICTION; HEALTH; CARCINOMAS; DOCETAXEL; THERAPY;
D O I
10.3109/07357900903275217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:953 / 959
页数:7
相关论文
共 33 条
[1]  
Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
[2]   Quantifying trade-offs:: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer [J].
Bernhard, J ;
Zahrieh, D ;
Coates, AS ;
Gelber, RD ;
Castiglione-Gertsch, M ;
Murray, E ;
Forbes, JF ;
Perey, L ;
Collins, J ;
Snyder, R ;
Rudenstam, CM ;
Crivellari, D ;
Veronesi, A ;
Thürlimann, B ;
Fey, MF ;
Price, KN ;
Goldhirsch, A ;
Hürny, C .
BRITISH JOURNAL OF CANCER, 2004, 91 (11) :1893-1901
[3]   Quality of life after adjuvant chemotherapy for breast cancer [J].
Broeckel, JA ;
Jacobsen, PB ;
Balducci, L ;
Horton, J ;
Lyman, GH .
BREAST CANCER RESEARCH AND TREATMENT, 2000, 62 (02) :141-150
[4]   Treatment decisions for breast carcinoma - Patient preferences and physician perceptions [J].
Bruera, E ;
Willey, JS ;
Palmer, JL ;
Rosales, M .
CANCER, 2002, 94 (07) :2076-2080
[5]   Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer [J].
Chang, JC ;
Wooten, EC ;
Tsimelzon, A ;
Hilsenbeck, SG ;
Gutierrez, MC ;
Elledge, R ;
Mohsin, S ;
Osborne, CK ;
Chamness, GC ;
Allred, DC ;
O'Connell, P .
LANCET, 2003, 362 (9381) :362-369
[6]   Molecular profiling of breast cancer: clinical implications [J].
S Cleator ;
A Ashworth .
British Journal of Cancer, 2004, 90 (6) :1120-1124
[7]   Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis [J].
Cole, BF ;
Gelber, RD ;
Gelber, S ;
Coates, AS ;
Goldhirsch, A .
LANCET, 2001, 358 (9278) :277-286
[8]   Measurement of gene expression in archival paraffin-embedded tissues - Development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay [J].
Cronin, M ;
Pho, M ;
Dutta, D ;
Stephans, JC ;
Shak, S ;
Kiefer, MC ;
Esteban, JM ;
Baker, JB .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) :35-42
[9]   A CLINICIAN GUIDE TO COST-EFFECTIVENESS ANALYSIS [J].
DETSKY, AS ;
NAGLIE, IG .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (02) :147-154
[10]   Systematic overview of cost-utility assessments in oncology [J].
Earle, CC ;
Chapman, RH ;
Baker, CS ;
Bell, CM ;
Stone, PW ;
Sandberg, EA ;
Neumann, PJ .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) :3302-3317